This story was first published in digitalhealth.net
Cancer Drugs Fund makes new treatments available on the NHS earlier
NHS patients in England are getting early access to new drugs for lung cancer and sarcoma after NICE says they should be available on the Cancer Drugs Fund (CDF).
Pembrolizumab for lung cancer and olaratumab for sarcoma are now available on the CDF at a discounted price while more information is gathered on their value.
A new rule made to NICE’s appraisal process for cancer drugs means that it can approve drugs that early studies show are effective but where more data is needed on their long-term benefits.
This rule also means that NICE can make recommendations earlier in the drug pipeline, meaning patients in England benefit sooner.
Professor Carole Longson, director of the NICE centre for health technology evaluation said: “With the changes that were made to the CDF, we are issuing guidance earlier than any other country in Europe. With companies working closely with us and NHS England we will continue to deliver on our promise to give people fast access to the most effective cancer drugs.”
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
